During commitment to the B cell lineage, pro-B cells initiate recombination of the immunoglobulin heavy-chain variable (V) gene segment to the diversity (D) and joining (J) gene segments. In-frame rearrangements allow the expression of immunoglobulin-µ heavy chain, which then assembles with immunoglobulin-associated α-and β-proteins and the surrogate light-chain complex (SLC; composed of λ5 and VpreB) to form the pre-B cell antigen receptor (pre-BCR) 1,2 . Initial signals transmitted through the pre-BCR act in synergy with those elicited through the interleukin 7 receptor (IL-7R) to expand the B cell progenitor pool 3, 4 .
A r t i c l e s
During commitment to the B cell lineage, pro-B cells initiate recombination of the immunoglobulin heavy-chain variable (V) gene segment to the diversity (D) and joining (J) gene segments. In-frame rearrangements allow the expression of immunoglobulin-µ heavy chain, which then assembles with immunoglobulin-associated α-and β-proteins and the surrogate light-chain complex (SLC; composed of λ5 and VpreB) to form the pre-B cell antigen receptor (pre-BCR) 1, 2 . Initial signals transmitted through the pre-BCR act in synergy with those elicited through the interleukin 7 receptor (IL-7R) to expand the B cell progenitor pool 3, 4 .
For subsequent development, pre-B cells must cease dividing and then initiate light-chain recombination, primarily at the immunoglobulin κ-chain locus (Igk) 4, 5 . These two fundamental processes are by necessity sequential, as concurrent replication and introduction of double-strand breaks during recombination would compromise genomic integrity 6 . It has been hypothesized that proliferating pre-B cells exit the cell cycle and initiate Igk recombination after termination of SLC expression 7 . However, constitutive expression of SLC does not impede Igk rearrangement 8 . Furthermore, loss of downstream components of the pre-BCR signaling cascade, including SLP-65 and PLC-γ2, arrests development at the cycling pre-BCR + stage [9] [10] [11] . Those and other observations 12 indicate that the signaling mechanisms that terminate proliferation and initiate Igk recombination are intrinsic to the pre-BCR.
The signaling intermediate Ras is linked to B lymphopoiesis. Expression of dominant negative Ras induces a developmental block at the pro-B cell stage 13 , whereas expression of constitutively active Ras can induce developmental progression 14 and Igk recombination 15 . The molecular mechanisms by which Ras contributes to Igk rearrangement and the relationship of these mechanisms to those controlling the cell cycle are not known.
Downstream of the pre-BCR, the interferon-regulatory factor family members IRF4 and IRF8 are required in vivo for initiation of Igk recombination, suppression of the SLC and exit from the cell cycle 16, 17 . Culture of Irf4 -/-Irf8 -/-bone marrow with IL-7 yields populations of actively cycling pre-BCR + cells, whereas reintroduction of IRF4 in the presence of IL-7 silences the SLC 17 and induces Igk recombination 18 . Although Irf4 -/-Irf8 -/-mice manifest a complete block in B lymphopoiesis in vivo, attenuation of IL-7R signaling in Irf4 -/-Irf8 -/-pre-B cell cultures induces exit from the cell cycle and Igk recombination 18 . These observations suggest the existence of two molecular pathways that function synergistically to activate Igk rearrangement: one that is independent of IRF4 and requires attenuation of IL-7R signaling, and another dependent on pre-BCR-induced IRF4 expression.
Several other transcription factors have been linked to regulation of the Igk locus 19 ; however, expression of the transcription factor E2A with the recombinases RAG-1 and RAG-2 is sufficient to induce Igk recombination in a nonlymphoid cell line 20 . Furthermore, genetargeting studies have demonstrated that mutation of the E2A-binding motifs in the intronic Igk enhancer (E κi ) reduces Igk rearrangement similar to ablation of the entire E κi (ref. 21) . Those and other studies 22 demonstrate that E2A is an important direct regulator of Igk transcription and recombination. The activity of E2A proteins and the regulation of E2A-dependent developmental events are modulated by expression of the DNA-binding inhibitors Id1-Id3 (ref. 23) .
The mechanisms that regulate Igk recombination have been studied intensely. In contrast, the important regulators that control cell cycle progression in pre-B cells have been identified only recently 24, 25 . Cyclin D3 expression is upregulated in pre-B cells and the pre-B cell proliferative expansion is ablated in cyclin D3-deficient (Ccnd3 -/-) mice 24 . Furthermore, exit from cell cycle and the initiation of Igk recombination are associated with termination of Ccnd3 transcription 24 . Therefore, to understand the relationships between the signaling elements that control exit from the cell cycle and Igk recombination, we first sought to identify the negative regulators of Ccnd3 transcription and relate them to those controlling E2A.
Here we demonstrate that pre-BCR-mediated activation of Ras-MEK-Erk couples exit from the cell cycle to Igk recombination. Downstream of the kinase Erk, Aiolos silenced Ccnd3, whereas reciprocal regulation of E2A and Id3 initiated Igk transcription. IL-7R antagonized Igk transcription through the transcription factor STAT5, which bound to E κi and prevented E2A recruitment. Our findings identify a central signaling pathway that controls pre-BCR development and provide a molecular framework for understanding how the balance between pre-BCR and IL-7R signaling determines cell fate.
RESULTS

Ras-MEK directs pre-B cell differentiation
To better understand how proliferation is regulated during B lymphopoiesis, we sought to identify the specific signaling pathways that suppress Ccnd3 transcription in pre-B cells. For these initial studies, we used cultured Irf4 -/-Irf8 -/-pre-B cells as our model of differentiation. In the presence of IL-7, these pre-BCR + cells continually proliferate. However, after attenuation of IL-7 signaling, they exit the cell cycle and initiate Igk recombination 16, 18 .
In complete media alone, withdrawal of IL-7 was associated with diminished abundance of mRNA encoding Ccnd3, Ccnd2 and Ccne1-Ccne2 (collectively called 'Ccne' here (encoding cyclins E1 and E2); Fig. 1a) as well as the corresponding protein products (Fig. 1b) . Initial pharmacological-inhibitor studies failed to identify any negative regulators of Ccnd3 transcription 24 . However, subsequent studies demonstrated that inhibiting either the kinase MEK or Erk abrogated IL-7 withdrawal-induced cyclin downregulation (Fig. 1a,b) .
We examined whether the MEK-Erk pathway could regulate processes necessary for Igk recombination. Transcription of Rag1 and Rag2 (Fig. 1c) and Igk germline (Fig. 1d) was induced after IL-7 withdrawal. Inhibition of either MEK or Erk attenuated transcription of both Rag1 and Rag2 and Igk germline after IL-7 withdrawal (Fig. 1c,d) . Inhibition of MEK for 24 h did not change surface pre-BCR expression (data not shown). These data suggested that signaling through the MEK-Erk pathway directly affects both cell cycle and the initiation of Igk recombination.
To determine if our observations were relevant to normal B lymphopoiesis, we examined Erk activation in various B cell progenitor populations. We isolated pro-B cells (B220 + CD43 hi IgM -), large pre-B cells (B220 + CD43 lo-neg IgM -) and small pre-B cells (B220 + CD43 lo-neg IgM -) from wild-type bone marrow by flow cytometry, made the cells permeable and stained them with antibodies to phosphorylated Erk. We found Erk activation in all three populations, with the most staining detected in large pre-B cells and the least detected in pro-B cells (Fig. 1e) .
The pattern of Erk activation paralleled that of pre-BCR expression, which is highest in large pre-B cells and is then attenuated after transition to the small pre-B cell stage 8 . To determine if pre-BCR expression augmented Erk activation, we infected cultured Rag2 -/-pro-B cells with control retrovirus (MIGR1-IRES-GFP) or retrovirus encoding the µ-chain and assessed cells positive for green fluorescent protein (GFP + ) by flow cytometry. Expression of µ-chain led to surface expression of a pre-BCR, and this was associated with more Erk activation (Fig. 1f) . 
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To assess the function of MEK-Erk activation, we isolated large and small pre-B cells by flow cytometry, treated the cells for 6 h in short-term culture with a MEK inhibitor and then assayed transcription of Ccnd3 and germline Igk (Fig. 1g,h ). Large pre-B cells had abundant Ccnd3 transcripts and small amounts of Igk germline transcripts relative to small pre-B cells. In both cell populations, MEK inhibition suppressed the abundance of Igk germline transcripts and augmented those of Ccnd3. These results confirmed our initial observations obtained with cultured Irf4 -/-Irf8 -/-pre-B cells and indicate that pre-BCR-mediated activation of MEK-Erk serves a central function in coordinating Ccnd3 suppression with the induction of Igk germline transcription.
To further explore the contributions of the MEK-Erk signaling pathway to B lymphopoiesis, we infected cultured Irf4 -/-Irf8 -/-pre-B cells with control retrovirus or retrovirus encoding either a dominant negative mutant of Ras (DN-Ras; N 17 -H-Ras) or MEK (DN-MEK; MKK1-E 8 -K 97 M; superscripted numbers indicate amino acid position). We isolated GFP-expressing cells by flow cytometry, expanded their populations in IL-7 and then cultured them in the presence or absence of IL-7. Both pharmacological inhibition and expression of DN-Ras or DN-MEK attenuated Erk activation (Fig. 2a) . Notably, IL-7 withdrawal did not substantially modulate Erk activation in Irf4 -/-Irf8 -/-cells, and Erk phosphorylation was relatively low in Rag2 -/-pro-B cells regardless of IL-7. These observations are consistent with the results above (Fig. 1e,f) and the findings of others indicating that Erk activation lies mainly downstream of the pre-BCR 26, 27 .
Ectopic expression of either DN-Ras or DN-MEK increased Ccnd3 mRNA in the presence of IL-7 and prevented the usual decrease associated with IL-7 withdrawal (Fig. 2b) . We found parallel changes in cyclin D3 protein expression (Fig. 2c) . Ectopic expression of both DN-Ras and DN-MEK similarly increased expression of cyclin D2 and cyclin E ( Supplementary Fig. 1a-c) . Ectopic expression of DN-Ras or DN-MEK did not substantially alter expression of Cdkn1a (encoding p21 Cip1 ; Supplementary Fig. 1d ) and only partially blunted Rag2/B2m
Igk germline/B2m the induction of Cdkn1b (encoding p27 Kip1 ) after IL-7 withdrawal (Supplementary Fig. 1e ).
We also analyzed the function of activation of Ras and MEK in cellcycle exit after IL-7 withdrawal. We cultured Irf4 -/-Irf8 -/-pre-B cells expressing either DN-Ras or DN-MEK in the presence or absence of IL-7 for up to 48 h. We permeabilized aliquots of cells, stained them with propidium iodide and analyzed them by flow cytometry. In the presence of IL-7, both DN-Ras and DN-MEK modestly increased the fraction of cells in S-G2M (Fig. 2d) . However, expression of either DN-Ras or DN-MEK greatly blunted the cell-cycle exit associated with IL-7 withdrawal; at 48 h after IL-7 withdrawal, when only 7% of control transfected cells were in S-G2M, 21% of those expressing DN-Ras and 18% of those expressing DN-MEK were in the cell cycle. These data indicate that escape from IL-7 is not sufficient to terminate pre-B cell proliferation. In addition, activation through the Ras-MEK pathway is needed to suppress Ccnd3 transcription and exit from the cell cycle.
We examined the function of Ras-MEK-Erk activation in regulating the mechanisms of Igk recombination. Withdrawal of IL-7 from cultured Irf4 -/-Irf8 -/-pre-B cells induced expression of Rag1 and Rag2 (Fig. 3a,b) and enhanced Igk germline transcription (Fig. 3c) . These responses were significantly attenuated by expression of either DN-Ras or DN-MEK.
To determine if the observed regulation of Rag1-Rag2 and Igk germline transcription affected Igk recombination, we isolated genomic DNA from aliquots of cultured Irf4 -/-Irf8 -/-pre-B cells expressing the control retrovirus MIGR1, DN-Ras or DN-MEK. We then subjected samples to PCR with oligonucleotide primers complementary to V κ and J κ 1-J κ 5 and visualized the products as described before 18 (results of a typical experiment, Fig. 3d ). We also quantitatively compared the relative band intensities corresponding to each (Fig. 3e) . Expression of either DN-Ras or DN-MEK significantly diminished Igk recombination. Therefore, the Ras-MEK-Erk signaling pathway seems to coordinate both exit from the cell cycle and Igk recombination in pre-B cells.
Aiolos induces exit from the cell cycle
We investigated whether the Ras-MEK-Erk pathway suppressed proliferation and induced Igk recombination through the same or different downstream signaling pathways. Aiolos is a lymphoid-restricted transcription factor that is specifically upregulated in pre-B cells 28 by pre-BCR-dependent signaling pathways 29 . Furthermore, pre-B cell proliferation is greater in Aiolos-deficient mice (Ikzf3 -/-; called 'Aiolos -/-' here) 30 . These findings prompted us to examine if Aiolos is involved in Ras-MEK-mediated exit from the cell cycle.
We characterized expression of Aiolos and the family member Ikaros 31 in isolated pro-B cells (B220 + CD43 hi IgM -) and pre-B cells (B220 + CD43 lo-neg IgM -) from wild-type bone marrow. As expected 29 , Aiolos expression was higher in pre-B cells than in pro-B cells, whereas expression of the gene encoding Ikaros (Ikzf1; called 'Ikaros' here) was similar in both populations (Fig. 4a) . We next determined if the Ras-MEK-Erk signaling pathway could modulate Aiolos expression. We cultured Irf4 -/-Irf8 -/-pre-B cells ectopically expressing either DN-Ras or DN-MEK in the presence or absence of IL-7 and then assayed the expression of Aiolos (Fig. 4b) and Ikaros (Fig. 4c) . Blocking the Ras-MEK pathway attenuated Aiolos expression but had no significant effect on Ikaros expression.
To determine if Aiolos could regulate Ccnd3, we used retroviral infection to establish cultured Irf4 -/-Irf8 -/-pre-B cell populations overexpressing mouse Aiolos. In both the presence and absence of IL-7, ectopic expression of Aiolos downregulated Ccnd3 mRNA (Fig. 4d) . Furthermore, regardless A r t i c l e s of IL-7 concentration, this was associated with a marked decrease in cells in S-G2M (Fig. 4e) . Expression of Aiolos suppressed the expression of Ccnd2 and Ccne but had no substantial effect on the expression of Cdkn1a or Cdkn1b (Supplementary Fig. 2a,b) . Furthermore, Aiolos did not modulate the expression of Rag1 or Rag2 or enhance Igk transcription ( Supplementary Fig. 2c,d ). These data suggest that in the context of pre-B cell differentiation, Aiolos functions downstream of Ras-MEK to specifically suppress Ccnd3 expression and facilitate exit from the cell cycle. To examine if Aiolos was required for Ras-mediated downregulation of cyclin D3, we isolated pre-B cells (B220 + CD43 lo-neg IgM -) by flow cytometry from wild-type and Aiolos -/-bone marrow and infected cultured cells with retrovirus encoding constitutively active Ras (CA-Ras). We then isolated GFP-expressing cells by flow cytometry and cultured them in IL-7. Expression of CA-Ras induced Aiolos expression in wild-type pre-B cells but not in Aiolos -/-pre-B cells (Fig. 5a) . CA-Ras also downregulated Ccnd3 in wild-type cells. In contrast, in Aiolos -/-pre-B cells, Ccnd3 mRNA was elevated and could not be suppressed by CA-Ras (Fig. 5b) . Ras-mediated Aiolos expression also controlled the expression of Ccnd2 and Ccne (Supplementary Fig. 3a,b) . Cell-cycle analysis showed that ectopic expression of CA-Ras attenuated the fraction of cells in S-G2M in wild-type but not Aiolos -/-pre-B cells (Fig. 5c) . These data indicate .d., a,b,d,e) . (Fig. 5a ) and in Irf4 -/-Irf8 -/-pre-B cells (Fig. 4b) was similar to the difference in Aiolos expression in wild-type pro-B cells versus pre-B cells (Fig. 4a) . However, overall Aiolos expression was lower in Irf4 -/-Irf8 -/-pre-B cells than in wild-type pre-B cells. This latter observation is consistent with published findings that IRF4 contributes to Aiolos induction 17 . However, our data indicate that sufficient Aiolos can be induced in the absence of IRF4 to mediate exit from the cell cycle.
E2A and Id3 determine Igk transcription
Igk transcription is dependent on E2A 20, 22 , which in turn is negatively regulated by the DNA-binding inhibitors 33) . Therefore, we examined if Ras-MEK-Erk activation could be involved in the coordinated regulation of E2A and Id3 during B lymphopoiesis. We cultured untransfected Irf4 -/-Irf8 -/-pre-B cells or cells expressing DN-Ras or DN-MEK in the presence or absence of IL-7 and assayed expression of Id1-Id3. Inhibition of the Ras-MEK pathway substantially augmented Id3 expression (Fig. 6a) . In contrast, DN-Ras or DN-MEK had no effect on Id1 expression and moderately enhanced Id2 expression (Supplementary Fig. 4a,b) . Immunoblot analysis of lysates of Irf4 -/-Irf8 -/-cells expressing either DN-Ras or DN-MEK confirmed that activation of the Ras-MEK-Erk pathway suppressed Id3 expression (Fig. 6b) . Immunoblot analysis of these same lysates also demonstrated that Ras-MEK induced expression of the transcription factor E47. Expression of Id3 and E47 was not substantially affected by IL-7.
Quantification of triplicate immunoblots showed that inhibition of Ras or MEK enhanced Id3 expression on average 330% and decreased E47 expression to 35% of control irrespective of IL-7 (Fig. 6c,d) . Although each observed change was moderate, the predicted change in the E47/Id3 ratio, and therefore of free E47, was substantial (900-1,000%). Therefore, we did electrophoretic mobility-shift assay (EMSA) with nuclear extracts from Irf4 -/-Irf8 -/-cells and an oligonucleotide probe corresponding to E1 box of E κi (Fig. 6d) . In the presence or absence of IL-7, we detected an E47-containing complex that bound the wild-type but not the mutant labeled oligonucleotide probe. This complex was attenuated by the addition of either antibody to E47 (anti-E47) or by excess unlabeled wild-type oligonucleotides. In contrast, the complex was not diminished by the addition of isotype-matched control antibodies or by unlabeled oligonucleotides containing mutations in the E2A-binding motif. MEK inhibition greatly attenuated the formation of detectable E47-containing binding complexes. In contrast, MEK inhibition had no detectable effect on the binding of STAT5 to its known binding site in the gene encoding the surface receptor FcγRI (ref. 34) . Consistent with published observations 18 , IL-7 had no substantial effect on the binding activity of nuclear E2A (Supplementary Fig. 5 ). These data indicate that MEK activation enhances E2A binding activity by coordinately regulating the expression of E2A and Id3.
To examine the potential importance of Ras-MEK-Erk regulation of Id3, we cultured Irf4 -/-Irf8 -/-pre-B cells expressing a retrovirusencoded fusion protein of the estrogen receptor and Id3 (ER-Id3) with or without IL-7 in the presence or absence of 4-OH-tamoxifen. Although expression of ER-Id3 and induction with tamoxifen had no significant effect on the expression of Rag1 and Rag2 (Fig. 7a) , Id3 ablated detectable Igk germline transcription (Fig. 7b) . This was associated with complete suppression of detectable V κ -to-J κ recombination (Fig. 7c) . Id3 induction had no effect on expression of the D-and E-type cyclins (Supplementary Fig. 4c ) or the cell-cycle inhibitors Cdkn1a and Cdkn1b (Supplementary Fig. 4d ). These data indicate Id3 is a specific regulator of Igk transcription in pre-B cells.
To investigate whether Id3 was needed to suppress Igk transcription in vivo, we cultured isolated wild-type or Id3 -/-pre-B cells in IL-7 and then subjected them to IL-7 withdrawal. Igk transcription was significantly enhanced in Id3 -/-pre-B cells in both the presence and absence of IL-7 (Fig. 7d) . Consistent with results obtained using ectopic Id3 expression, the expression of Rag1 and Rag2 was not altered in Id3 -/-pre-B cells compared with that in wild-type cells (Fig. 7e) ; furthermore, the expression of Ccnd2, Ccnd3 and Ccne was similar in wildtype and Id3 -/-pre-B cells (Supplementary Fig. 6 ). To determine if Id3 
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regulates Igk recombination in vivo, we isolated large and small pre-B cells from wild-type and Id3 -/-mice, stained the cells with antibody to immunoglobulin κ-chain and analyzed them by flow cytometry. A greater fraction of Id3 -/-large and small pre-B cells expressed κ-chain on their cell surface, consistent with κ-chain dysregulation (Fig. 7f) . These data indicate that Ras-MEK-Erk enhances Igk transcription through the coordinated regulation of E2A and Id3.
STAT5 regulates the accessibility of E i to E2A For Ras-MEK-Erk activation to efficiently induce exit from the cell cycle and Igk recombination, pre-B cells must escape the effects of IL-7. Given our data, we predicted that IL-7 inhibits differentiation by opposing the Ras-MEK-Erk signaling pathway. However, IL-7 did not significantly alter Aiolos expression (Fig. 4b) or E2A-binding activity 18 ( Supplementary Fig. 5 ). This suggests that IL-7 modulates the activities of Ras-MEK-Erk downstream of Aiolos and E2A. To examine this possibility, we first identified which IL-7R-dependent signaling pathways enhance Ccnd3 transcription and inhibit Igk transcription. Downstream of IL-7R, there are two main signaling pathways: Janus kinase 3-STAT5 and phosphatidylinositol-3-OH kinase-Akt 35 . Therefore, we determined if retrovirus-mediated expression of either CA-STAT5B 36 or CA-Akt 37 could replace the biological activities of IL-7 in cultures of Irf4 -/-Irf8 -/-pre-B cells. CA-STAT5B enhanced Ccnd3 expression in IL-7-treated cells and prevented the attenuation associated with IL-7 withdrawal (Fig. 8a) . CA-Akt did not significantly affect Ccnd3 expression. CA-STAT5B also repressed Igk germline transcription in cells cultured with or without IL-7 (Fig. 8b) . In contrast, CA-Akt repressed the induction of Rag1 and Rag2 after IL-7 withdrawal, but CA-STAT5B did not (Fig. 8c) . From these data, we conclude that that STAT5 is the main downstream signaling effector of IL-7R-mediated transcription of Ccnd3 and Igk 38 .
IL-7-mediated Igk repression is dependent on E κi . Furthermore, repression is associated with inhibition of the binding of E2A to E κi in vivo 18 . Therefore, we next examined if STAT5 could modulate the binding of E2A to E κi . We obtained aliquots of Irf4 -/-Irf8 -/-cells cultured in the presence or absence of IL-7 and subjected them to quantitative chromatin immunoprecipitation (ChIP) with antibodies to STAT5B (Fig. 8d) . STAT5B bound to E κi in an IL-7-dependent manner. Binding was robust and similar to that obtained for the Cish promoter, a known STAT5 target 34 . In contrast, there was little detectable binding of STAT5 on the promoters of control genes encoding U7 small nuclear RNA and α-amylase.
We next investigated whether STAT5B could attenuate the binding of E2A to E κi . We cultured Irf4 -/-Irf8 -/-pre-B cells expressing CA-STAT5B or control cells in the presence or absence of IL-7. ChIP analysis showed enhanced binding of E47 to endogenous E κi after IL-7 withdrawal (Fig. 8e) . This was attenuated by expression of CA-STAT5B. These data suggest that STAT5 inhibits Igk transcription downstream of IL-7R by directly limiting the accessibility of E κi to E2A.
DISCUSSION
The differentiation of pre-B cells into immature B cells is thought to occur when they escape pro-proliferative IL-7R signals 18 . Our findings suggest that this is not sufficient. Pre-BCR-mediated activation of Ras-MEK-Erk is also needed to orchestrate the principal molecular events of this developmental transition: exit from the cell cycle and Igk recombination. Erk directs these outcomes by divergent mechanisms, using lineage-restricted and developmentally restricted downstream effector molecules. The identification of a central, IL-7R-modulated differentiation pathway provides a framework for understanding how signaling through the two principal receptors that dictate pre-B cell fate, the pre-BCR and IL-7R, coordinately regulate proliferation and differentiation.
A major function of the Ras-MEK-Erk pathway was to silence Ccnd3 and terminate proliferation. This result was unexpected because Ras induces proliferation in a variety of cell types 39 . However, the unique antiproliferative effect of Ras in pre-B cells was dependent on Aiolos, a lineage-and development-restricted transcription factor 29 , which coupled Ras activation to the silencing of Ccnd3. A central role for Aiolos in cell cycle termination is consistent with the finding that Aiolos -/-mice have more proliferating pre-B cells 30 . Furthermore, Aiolos is upregulated by expression of the pre-BCR 28, 29 . In contrast to the necessity for Aiolos in regulating pre-B cell proliferation, the family member Ikaros 28 seemed to have no substantial role. Aiolos also suppresses SLC expression 29 , which indicates that it may silence a program of pre-B cell-specific gene products.
Although it is clear that Aiolos is required for Ras-mediated silencing of Ccnd3, it is likely that Ras is not the only inducer of Aiolos. Ras inhibition only partially attenuated Aiolos expression. The transcription factor IRF4 can also induce Aiolos 17 in pre-B cells. Although it is compromised, Aiolos induction in Irf4 -/-Irf8 -/-pre-B cells is sufficient to allow exit from the cell cycle and Igk recombination.
In addition to silencing Ccnd3, Ras-MEK-Erk augmented Igk transcription by enhancing E2A expression and downregulating Id3. Ras-MEK-Erk induced only moderate changes in the expression of each protein. However, this 'translated' into a large increase in E2A-binding activity. This is in contrast to published work showing that Ras induces Id3 expression and attenuates E2A activity in double-positive thymocytes 40 . However, the Egr transcription factors that upregulate Id3 in thymocytes were only transiently suppressed after MEK inhibition in Irf4 -/-Irf8 -/-pre-B cells (data not shown). Therefore, it is not unexpected that T cell antigen receptor-dependent signals in double-positive thymocytes would regulate Id3 differently than do signals through the pre-BCR.
Downstream of the Ras-MEK-Erk pathway, the specific molecular events of development were mediated by discrete and nonoverlapping mechanisms. Aiolos repressed Ccnd3 transcription but had no effect on cell-cycle inhibitors or on the mediators of Igk recombination. Conversely, E2A enhanced Igk transcription but had no substantial effect on the cell-cycle machinery or on expression of Rag1 and Rag2. This last finding is consistent with prior observations that E2A is required for initial expression of Rag1 and Rag2 in pro-B cells but not for subsequent receptor-induced expression 41 .
Our observations may help resolve several apparent discrepancies in the literature concerning the role of Ras in lymphocyte development. Inhibiting the Ras-MEK-Erk pathway, either by expression of DN-Ras 13 or by lineage-specific mutation of the genes encoding Erk1 and Erk2, induces a block at the pro-B cell stage 42 . In mice with homozygous deficiency in Erk1 and Erk2, this is associated with a proliferative defect in the remaining CD19 + CD43 + cells and higher expression of SLC. In contrast, transgenic expression of CA-Ras throughout development induces extensive Igk rearrangement 15 . We would argue that these two phenotypes arise from differences in the expression of Ras targets in pro-B cells and pre-B cells. In particular, the upregulation of Aiolos in pre-B cells is predicted to change the outcome of Ras activation.
Tracing the signaling pathways downstream of Ras-MEK-Erk showed how IL-7R can suppress pre-BCR-mediated differentiation. Ras activation greatly increases nuclear E2A binding activity. However, this is not sufficient to induce Igk transcription, as E2A cannot bind E κi unless IL-7R signaling is attenuated. This suppressive function of IL-7R is mediated by STAT5 and is associated with the direct binding of STAT5 to E κi . It is not clear how STAT5 limits E κi accessibility. However, STAT5 is able to both repress 43 and activate 44 transcription.
In addition to repressing Igk transcription, STAT5 coordinately enhanced Ccnd3 transcription regardless of pre-BCR signaling. The dominance of STAT5 at the Igk and Ccnd3 loci provides a molecular explanation for why proliferation prevails over Igk recombination when both the IL-7R and the pre-BCR are transmitting signals.
From our data, a picture emerges in which crucial molecular determinants of B lymphopoiesis are regulated by opposing signaling pathways that intersect at specific targets. By coordinately upregulating E2A and suppressing Ccnd3 transcription, the Ras-MEK-Erk pathway serves a necessary and central function in the transition from proliferation to Igk recombination. This Ras-mediated differentiation program is modulated by STAT5, which suppresses the activities of specific downstream Erk targets. It is through these and other signaling networks 24, 45 that the balance between IL-7R and pre-BCR signaling determines if a pre-B cell divides or undergoes Igk recombination.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
